Since the present study demonstrates that PDCD11 regulates G2/M checkpoint through modulation of p53-CDK1 and CDC25C-CDK1 signaling pathways (Figs. 1 and 2), we believe that PDCD11 is a key node in the cell-cycle networks, also a potential target for CRC therapy. This evidence concerns the gene CDC25C and colorectal carcinoma.